StreetInsider.com News Articles

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

Mon, 11 Nov 2024 16:05:00 -0500

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) --

-- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) --

-- Progressing through court-administered financial restructuring process with continued interest from multiple parties

EMERYVILLE, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (OTC: GRTSQ), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced encouraging updated

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

Mon, 11 Nov 2024 16:05:00 -0500

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) --

-- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) --

-- Progressing through court-administered financial restructuring process with continued interest from multiple parties

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

Mon, 11 Nov 2024 16:05:00 -0500

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) --

-- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) --

-- Progressing through court-administered financial restructuring process with continued interest from multiple parties

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

Mon, 11 Nov 2024 16:05:00 -0500

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) --

-- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) --

-- Progressing through court-administered financial restructuring process with continued interest from multiple parties

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

Mon, 11 Nov 2024 16:05:00 -0500

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) --

-- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) --

-- Progressing through court-administered financial restructuring process with continued interest from multiple parties

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

Mon, 11 Nov 2024 16:05:00 -0500

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) --

-- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) --

-- Progressing through court-administered financial restructuring process with continued interest from multiple parties

Form SC 13G/A Gritstone bio, Inc. Filed by: MORGAN STANLEY

Thu, 07 Nov 2024 17:10:00 -0500

si-local-file:///var/storage/secattach/20241107/23945587.html

Form SC 13G/A Gritstone bio, Inc. Filed by: MORGAN STANLEY

Thu, 07 Nov 2024 17:10:00 -0500

si-local-file:///var/storage/secattach/20241107/23945587.html

Form SC 13G/A Gritstone bio, Inc. Filed by: MORGAN STANLEY

Wed, 06 Nov 2024 17:35:00 -0500

si-local-file:///var/storage/secattach/20241106/23937282.html

Form SC 13G/A Gritstone bio, Inc. Filed by: MORGAN STANLEY

Wed, 06 Nov 2024 17:35:00 -0500

si-local-file:///var/storage/secattach/20241106/23937282.html

Form 8-K Gritstone bio, Inc. For: Oct 11

Wed, 16 Oct 2024 16:06:00 -0500

si-local-file:///var/storage/secattach/20241016/23844116.html

Form 8-K Gritstone bio, Inc. For: Oct 11

Wed, 16 Oct 2024 16:06:00 -0500

si-local-file:///var/storage/secattach/20241016/23844116.html

Form 8-K Gritstone bio, Inc. For: Oct 10

Thu, 10 Oct 2024 08:30:00 -0500

si-local-file:///var/storage/secattach/20241010/23823396.html

Form 8-K Gritstone bio, Inc. For: Oct 10

Thu, 10 Oct 2024 08:30:00 -0500

si-local-file:///var/storage/secattach/20241010/23823396.html

Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure